New Century Health Associate Chief Medical Officer Dr. Monica Soni explores some of the most prevalent health inequities in cancer care and shares strategies for how to address them.
Other content in this Stream
![Trends Impacting the Future of Cancer Care](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTk4OTY4JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzVkMTEwZWZjNzI1ZWMuanBnJnZlcnNpb249MDAwMCZzaWc9NWE5MWQzMDgxOWMzMWVlMTYwYTgyNjg1Y2Y0YzEyZWU%25253D&size=1&version=1674772087&sig=8db78a20315f53fbaa9650c3413d6e61&default=hubs%2Ftilebg-blogs.jpg)
Our VP of market strategy shares her insights with Becker's Hospital Review.
![Communicating Prognosis: A Core Competency of Patient-Centered Oncology Care](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTk4OTY4JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzVkOTM2MTU0MmM2NmEuanBnJnZlcnNpb249MDAwMCZzaWc9OGFmMWZiNGE3YTNjOWQxZDBmNWIwODJkMzk0YzUxNjc%25253D&size=1&version=1677113364&sig=f0c7bf81de86b01c906fc86773b79925&default=hubs%2Ftilebg-blogs.jpg)
Our associate CMO writes in ASCO Post about an often-overlooked skill.
![Embracing Hope, Naming the Uncomfortable, and Empowering the Patient in Palliative Care](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTk4OTY4JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzYzNzUzMjdkYTg1ZTMuUE5HJnZlcnNpb249MDAwMCZzaWc9NDllMWI5MWRiN2M5MWI3NjJhZmM5YmJjMzMwZTNlYzc%25253D&size=1&version=1675801209&sig=a3168b056212ea8063f6cf0d46d98d8b&default=hubs%2Ftilebg-blogs.jpg)
Our CMO Dr. Monica Soni, and American Cancer Society's Chief Patient Officer Dr. Arif Kamal discuss current challenges and the future of effective palliative care.
![A Call for Creativity: The Shades of Gray in Delivery of Goal-Concordant Care](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTk4OTY4JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzVkOTM2MWRjMDYxYjAuanBnJnZlcnNpb249MDAwMCZzaWc9OTQxNTQ2N2UxNzE4ZmI2YmJmMTM0YWFmNzg5YTRhZGM%25253D&size=1&version=1668694081&sig=83a8568d95711f88418d114652cd0cb3&default=hubs%2Ftilebg-blogs.jpg)
Our associate CMO writes for the ASCO Post about the lessons she learned from a loved one's experience with terminal cancer.
![Up, Up and Not Going Away: Cancer Drug Prices](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTk4OTY4JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzVkMTExYjViNWM1YTYuanBnJnZlcnNpb249MDAwMCZzaWc9MThiYWNmNjUzZjIyYTA1MjFkNjc3MzMwY2RjNWFjOTU%25253D&size=1&version=1666624438&sig=83c62b560365caa608bae02d5de95e19&default=hubs%2Ftilebg-blogs.jpg)
Our chief medical officer speaks with Managed Healthcare Executive about the financial toxicity of cancer treatment.
![When Equality and Health Equity Diverge](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTk4OTY4JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzYzMjA5NjZjM2JiNjUuanBnJnZlcnNpb249MDAwMCZzaWc9N2FlMTI1MjY0ZjdhYTQzZjJhMDFiYWFhYzFmMTUyNDk%25253D&size=1&version=1666977574&sig=c672d3f80601ae98f44b04334fd3db7f&default=hubs%2Ftilebg-blogs.jpg)
Treating patients the same isn't always the path to improved outcomes, writes our associate chief medical officer.
![People with Terminal Cancer Need to Know They Are Dying](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTk4OTY4JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzVkOTM2MTJjZTViYjEuanBnJnZlcnNpb249MDAwMCZzaWc9MjBjMmNiN2Y3NmUyZTJmYTQxOTU4M2QwZWNhNTEyNjU%25253D&size=1&version=1665679078&sig=64fc52c418b09f95f46f9ad1d70c4dc7&default=hubs%2Ftilebg-blogs.jpg)
Our associate chief medical officer writes in STAT on the need for greater transparency by physicians.
![New Century Health and Humana Surpass Monumental 10 Years of Partnership in High-Value Oncology Care](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTk4OTY4JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzYyYThhNjIxNjZkMzcuUE5HJnZlcnNpb249MDAwMCZzaWc9OTczNWYzZjRhMWZmMjNhOGE1ZDVjNGU3OTA1NjFkZmI%25253D&size=1&version=1665679078&sig=0f7e89bbc49afd269565bf8478c53b0b&default=hubs%2Ftilebg-blogs.jpg)
New Century Health and Humana's national partnership improves patient experience and eases administrative burdens on provider practices.
![Leading Causes: Interrogating the “Why” Behind Health Inequity in Cancer Care](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTk4OTY4JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzYyN2FhM2ZmNDc2ZTAuUE5HJnZlcnNpb249MDAwMCZzaWc9ZTA5YmEwY2E5Y2NkMDJlNDhiNWVhY2IyMGQyOGYzODQ%25253D&size=1&version=1665679078&sig=b1cb72a386ff91a438a397bf219fa612&default=hubs%2Ftilebg-blogs.jpg)
How do social determinants of health impact outcomes in cancer care? New Century Health Associate CMO Dr. Monica Soni and Radiation Oncologist Dr. Onyinye Balogun discuss.
![Bridging the Gaps in Advance Care Planning in Oncology](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTk4OTY4JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzYyNWYzODYwYmQ4MDAuanBnJnZlcnNpb249MDAwMCZzaWc9YjQyZDU0YTNiZGVlNTRiNzJjZGMxOWE5MGI5OTczZGM%25253D&size=1&version=1665679078&sig=cd4f24e2ee2f8b2e67b3e2c5427698c3&default=hubs%2Ftilebg-blogs.jpg)
New Century Health and our Vital Decisions solution seek to ensure more cancer patients receive end-of-life care that aligns with their wishes.
![New Century Health Partner Cancer Care Specialists of Illinois Earns $3.6 Million from Medicare through Federal Oncology Care Model](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTk4OTY4JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzVkMTExYmRiYThmOTEuanBnJnZlcnNpb249MDAwMCZzaWc9YmE1Mzk2NGEyNWYxMzhmOTFjYjEzOWFkYmVmY2E4NjU%25253D&size=1&version=1665679078&sig=b04802ea2f35430072bae196d3318f77&default=hubs%2Ftilebg-blogs.jpg)
NCH’s high-value clinical oncology pathways, patient triage programs and provider engagement strategies help community practice to succeed in value-based payment program.
![Still Bracing for the Surge in Advanced Cancer Cases](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTk4OTY4JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzYyMjBkOGE0YzE4ZGMuanBnJnZlcnNpb249MDAwMCZzaWc9MGYzMTM5OTZiZWNhODA0Y2M2ZmIzYWMwMTk5YjM5Mjk%25253D&size=1&version=1665679078&sig=c51669151627144c644f4311ad174f6c&default=hubs%2Ftilebg-blogs.jpg)
The predicted wave of late-stage cancers is taking longer to materialize than we expected.
![The Pandemic's Disproportionate Impact on Health Care Disparities and Cancer](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTk4OTY4JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzVkMTExYmRiYThmOTEuanBnJnZlcnNpb249MDAwMCZzaWc9YmE1Mzk2NGEyNWYxMzhmOTFjYjEzOWFkYmVmY2E4NjU%25253D&size=1&version=1665679078&sig=b04802ea2f35430072bae196d3318f77&default=hubs%2Ftilebg-blogs.jpg)
Our associate chief medical officer shares her insights with the American Journal of Managed Care's podcast.
![Cancer Moonshot 2.0: Three Big Questions to Track](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTk4OTY4JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzYyMTNjYTgxMDRjYzYuanBnJnZlcnNpb249MDAwMCZzaWc9OTUxYjUxOGQ5MmMwOWJkMjNjNzcyMjI4NzdjYjcxZGU%25253D&size=1&version=1665679078&sig=a46c34392d6d7a20c9c7d4be94179d9d&default=hubs%2Ftilebg-blogs.jpg)
Which components of the recently announced Cancer Moonshot should get high priority for the initiative to succeed? Our chief medical officer, Dr. Andrew Hertler, outlines three key questions to track.
![Accelerated Drug Approvals Present a Mounting Challenge to Oncologists](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTk4OTY4JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzYxZDcxN2M2Mjc5MGUucG5nJnZlcnNpb249MDAwMCZzaWc9NTg2MjI2OTEwYmZkZjgwNzQ4ODlkNDAwZDQ0ZjAyMzE%25253D&size=1&version=1665679078&sig=42ea73e5b9a362fb431f0beb52b419f2&default=hubs%2Ftilebg-blogs.jpg)
Dr. Andrew Hertler explains three key criteria for evaluating fast-tracked drugs.
![Patient Impact Story: Clinical Review Catches Potential Medical Error](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTk4OTY4JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzYxYWY4NTE0OTA1NjAuanBnJnZlcnNpb249MDAwMCZzaWc9ZDBjMzYzYmE0M2M4YWI5NmZhYjY5NTk2MzgzN2QyYjQ%25253D&size=1&version=1665679078&sig=a3afce6797a043ca9044bcd63f436c04&default=hubs%2Ftilebg-blogs.jpg)
Red flags cause clinical reviewers to question a radiation oncologist’s diagnosis.
![Panel Discussion: Oncology Care Reimagined](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTk4OTY4JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzVlYmQ3MzdkMTg5ODkucG5nJnZlcnNpb249MDAwMCZzaWc9NTRiMmE4NTA1N2I1MGIwZDNiNThjMDFiYjI4MWNjNDg%25253D&size=1&version=1665679078&sig=390e08c0b69b5e2daa9d517e37503402&default=hubs%2Ftilebg-blogs.jpg)
Health plan clinical leaders joined us for an insightful discussion on the path toward high-value cancer care.
![Location, Location, Location. That Also Applies to Cancer Treatment.](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTcyNTM1JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzViN2YxODEwM2RhYzQucG5nJnZlcnNpb249MDAwMCZzaWc9NDhjNjliNzVmMDhhMzczYmFiZmFlMDVkODhiMTAxNTU%25253D&size=1&version=1665679078&sig=3b388292099d19fbfa20f1329c417993&default=hubs%2Ftilebg-blogs.jpg)
Home-based chemotherapy infusions may offer convenience but also raise a host of questions.
![Shouldering the Burden and Financial Toxicity of Part D Cancer Drugs](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTk4OTY4JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzYxOGMxNWZmZTcwYjkuanBnJnZlcnNpb249MDAwMCZzaWc9MTMzNjExZmY4MDJlYzBlZTkxOWEzZmMwZDRhZDE4NTg%25253D&size=1&version=1665679078&sig=e509cc3b0f99ad1c4d48ab1ef3459992&default=hubs%2Ftilebg-blogs.jpg)
Discussing drug costs should be a core tenet of shared decision-making.
![Specialty Therapies Offering Incremental Benefit Shouldn’t Be Added to Clinical Pathways, Hertler Says](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTk4OTY4JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzVkOTM2MjdlOTJjNDcucG5nJnZlcnNpb249MDAwMCZzaWc9NDMyMGZkMjcyZDAyOGRjNjg0ODBhZmIwMGM5ZjA5ZmI%25253D&size=1&version=1665679078&sig=a9a99279d03d2ed0357706fa90c10c67&default=hubs%2Ftilebg-blogs.jpg)
Evidence-Based Oncology interviews our CMO about mismatches between drug costs and efficacy.